Table 9.
Risk of presenting clinically significant pathology, advanced neoplasia and cancer according to fecal hemoglobin concentration adjusted by sex and age.
| p-value | OR (95%CI) | |
|---|---|---|
| Clinically significant pathology | ||
| Q1 (<47) | Reference | |
| Q2 (47–110.6) | 0.144 | 1.9 (0.8–4.5) |
| Q3 (110.6–1069.4) | 0.004 | 3.6 (1.5–8.6) |
| Q4 (>1069.4) | <0.001 | 9.6 (3.7–24.9) |
| Advanced neoplasia | ||
| Q1 (<47) | Reference | |
| Q2 (47–110.6) | 0.087 | 2.3 (0.9–5.8) |
| Q3 (110.6–1069.4) | 0.030 | 2.8 (1.1–7.2) |
| Q4 (>1069.4) | 0.001 | 4.9 (1.9–12.7) |
| Cancer | ||
| Q1 (<47) | Reference | |
| Q2 (47–110.6) | 0.124 | 3.8 (0.7–20.2) |
| Q3 (110.6–1069.4) | 0.075 | 4.5 (0.9–23.7) |
| Q4 (>1069.4) | 0.001 | 16.3 (3.4–78.5) |
Bold values highlight the statistically significant data.